Seven years after it paid almost three quarters of a billion dollars for US-based Sagent, troubled Nichi-Iko is offloading the struggling business.

Troubled Japanese firm Nichi-Iko has currently has ¥55.8bn of debt forgiveness, which may expand to ¥98.5bn in the future. It currently faces regular payments until 2033 to settle all of its debts.

Nichi-Iko still has a long road to recovery ahead as it attempts to get its Toyama plant back on its feet.

Brii’s antibody combo therapy nears approval in China, based on data from a late-stage study conducted outside the country.